{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=alcohol+condition&page=2", "query": { "intervention": "alcohol condition", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=alcohol+condition&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T01:10:05.807Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01857934", "title": "Therapy for Children With Advanced Stage Neuroblastoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuroblastoma" ], "interventions": [ { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "topotecan", "type": "DRUG" }, { "name": "hu14.18K322A", "type": "BIOLOGICAL" }, { "name": "peripheral blood stem cell harvest", "type": "PROCEDURE" }, { "name": "surgical resection", "type": "PROCEDURE" }, { "name": "cisplatin", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "doxorubicin", "type": "DRUG" }, { "name": "vincristine", "type": "DRUG" }, { "name": "busulfan", "type": "DRUG" }, { "name": "melphalan", "type": "DRUG" }, { "name": "peripheral blood stem cell transplantation", "type": "BIOLOGICAL" }, { "name": "natural killer cell infusion", "type": "BIOLOGICAL" }, { "name": "radiation therapy", "type": "RADIATION" }, { "name": "GM-CSF", "type": "BIOLOGICAL" }, { "name": "G-CSF", "type": "BIOLOGICAL" }, { "name": "mesna", "type": "DRUG" }, { "name": "levetiracetam", "type": "DRUG" }, { "name": "interleukin-2", "type": "BIOLOGICAL" }, { "name": "Isotretinoin", "type": "DRUG" }, { "name": "CliniMACS", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "PROCEDURE", "RADIATION", "DEVICE" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 153, "start_date": "2013-07-05", "completion_date": "2025-12-31", "has_results": true, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01857934" }, { "nct_id": "NCT03345407", "title": "Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Placebo ELLIPTA", "type": "DRUG" }, { "name": "Nemiralisib ELLIPTA 50 µg", "type": "DRUG" }, { "name": "Nemiralisib ELLIPTA 100 µg", "type": "DRUG" }, { "name": "Nemiralisib ELLIPTA 250 µg", "type": "DRUG" }, { "name": "Nemiralisib ELLIPTA 500 µg", "type": "DRUG" }, { "name": "Nemiralisib ELLIPTA 750 µg", "type": "DRUG" }, { "name": "Albuterol (Salbutamol) MDI or nebules", "type": "DRUG" }, { "name": "Standard of care therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 943, "start_date": "2017-11-28", "completion_date": "2019-01-10", "has_results": true, "last_update_posted_date": "2021-07-14", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 21, "location_summary": "Mobile, Alabama • Colorado Springs, Colorado • Daytona Beach, Florida + 17 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Adairsville", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03345407" }, { "nct_id": "NCT01963234", "title": "Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Substance Use Disorders", "HIV" ], "interventions": [ { "name": "Seva", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 439, "start_date": "2014-03", "completion_date": "2017-06-30", "has_results": true, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 3, "location_summary": "Missoula, Montana • The Bronx, New York • Madison, Wisconsin", "locations": [ { "city": "Missoula", "state": "Montana" }, { "city": "The Bronx", "state": "New York" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01963234" }, { "nct_id": "NCT01949545", "title": "Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors", "Hematologic Malignancies", "Hepatic Impairment" ], "interventions": [ { "name": "Carfilzomib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2013-10", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2017-05-02", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 5, "location_summary": "Detroit, Michigan • Durham, North Carolina • Canton, Ohio + 2 more", "locations": [ { "city": "Detroit", "state": "Michigan" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Canton", "state": "Ohio" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01949545" }, { "nct_id": "NCT00536900", "title": "Clinical Trial of Abstinence-Linked Money Management", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Substance Abuse" ], "interventions": [ { "name": "Advisor-Teller Money Manager", "type": "BEHAVIORAL" }, { "name": "FIT", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2004-06", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2020-03-30", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00536900" }, { "nct_id": "NCT04522973", "title": "The Impact of Oral Ethanol and Vaped Ethanol on the Evaluation of Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Electronic Cigarette Use" ], "interventions": [ { "name": "Beverage with ethanol and E-cigarette liquid with ethanol", "type": "OTHER" }, { "name": "Beverage with ethanol and E-cigarette liquid without ethanol", "type": "OTHER" }, { "name": "Beverage without ethanol and E-cigarette liquid with ethanol", "type": "OTHER" }, { "name": "Beverage without ethanol and E-cigarette liquid without ethanol", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "21 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2023-04-21", "completion_date": "2024-07-18", "has_results": true, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04522973" }, { "nct_id": "NCT03235531", "title": "Assessment of Valproate on Ethanol Withdrawal", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alcohol Dependence", "Alcohol Withdrawal Syndrome", "Trauma", "Heavy Drinking", "Alcohol Use Disorder" ], "interventions": [ { "name": "Valproate", "type": "DRUG" }, { "name": "Lorazepam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CAMC Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2017-07-11", "completion_date": "2019-06-25", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 2, "location_summary": "Charleston, West Virginia", "locations": [ { "city": "Charleston", "state": "West Virginia" }, { "city": "Charleston", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03235531" }, { "nct_id": "NCT00108628", "title": "Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-traumatic Stress Disorder" ], "interventions": [ { "name": "Imagery Rehearsal", "type": "BEHAVIORAL" }, { "name": "Sleep and Nightmare Management", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 134, "start_date": "2004-04", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2015-02-18", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00108628" }, { "nct_id": "NCT03583372", "title": "An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overactive Bladder" ], "interventions": [ { "name": "Vibegron", "type": "DRUG" }, { "name": "placebos", "type": "DRUG" }, { "name": "Tolterodine Tartrate ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Urovant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 506, "start_date": "2018-06-14", "completion_date": "2019-07-25", "has_results": true, "last_update_posted_date": "2021-03-18", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 107, "location_summary": "Mobile, Alabama • Tempe, Arizona • Tucson, Arizona + 90 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Cerritos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03583372" }, { "nct_id": "NCT00445744", "title": "Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Myelodysplastic Syndromes", "de Novo Myelodysplastic Syndromes", "Essential Thrombocythemia", "Myelodysplastic Syndrome With Isolated Del(5q)", "Polycythemia Vera", "Previously Treated Myelodysplastic Syndromes", "Primary Myelofibrosis", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Secondary Acute Myeloid Leukemia", "Secondary Myelodysplastic Syndromes", "Secondary Myelofibrosis", "Untreated Adult Acute Myeloid Leukemia", "Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies" ], "interventions": [ { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "busulfan", "type": "DRUG" }, { "name": "tacrolimus", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "cytogenetic analysis", "type": "GENETIC" }, { "name": "flow cytometry", "type": "OTHER" }, { "name": "pharmacological study", "type": "OTHER" }, { "name": "pharmacogenomic studies", "type": "OTHER" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "allogeneic hematopoietic stem cell transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "GENETIC", "OTHER", "PROCEDURE" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "65 Years", "sex": "ALL", "summary": "Up to 65 Years" }, "enrollment_count": 52, "start_date": "2006-12", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2018-01-02", "last_synced_at": "2026-09-23T01:10:05.807Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00445744" } ] }